News | November 13, 2023
Glenmark Pharma reports Q2 FY24 loss at Rs. 62 Cr
European operations' revenue grew 58.4% to Rs 599.7 crore
European operations' revenue grew 58.4% to Rs 599.7 crore
PhytoSquene now available for clinical and commercial use
The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
The European Commission approved the use of Carbopol as an additive for liquid and solid food supplements in the EU
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
New Board of Directors and management team at Suven Pharma also appointed
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Subscribe To Our Newsletter & Stay Updated
